Mylan Technologies

Mylan strives to design, develop and manufacture high quality, innovative transdermal drug-delivery systems—adhesive patches that deliver medication through the skin. These medicines treat a variety of conditions across several therapeutic categories.

As we bring new transdermal products to market in these and other categories, our expertise continues to focus on coating, die cutting, packaging, material selection and formulation.


1000 Mylan Blvd Canonsburg, PA 15317
Tel: 724-514-1800

PharmTech News Articles

FDA issued a warning letter to Cixi Zhixin Bird Clean-Care Product Co., Ltd for violations of cGMP for finished pharmaceuticals.

The company announced an investment in a new facility in Dundalk, County Louth, Ireland.

Pharmco Laboratories received an FDA warning letter for significant violations of CGMP for finished drugs and APIs at its Florida, US facility as well as misbranding of over-the-counter (OTC) acne and sunscreen drug products.

Novo Nordisk entered a research collaboration with the University of Oxford focused on Type 2 diabetes.